Christian Thomas Farrar, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protons | 10 | 2023 | 1113 | 1.330 |
Why?
|
| Magnetic Resonance Imaging | 39 | 2024 | 36741 | 1.170 |
Why?
|
| Oncolytic Virotherapy | 3 | 2021 | 520 | 0.950 |
Why?
|
| Genes, Reporter | 3 | 2023 | 1524 | 0.940 |
Why?
|
| Gadolinium | 4 | 2017 | 964 | 0.550 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 5 | 2016 | 662 | 0.510 |
Why?
|
| Liver Cirrhosis, Experimental | 1 | 2015 | 30 | 0.490 |
Why?
|
| RNA Probes | 2 | 2014 | 111 | 0.470 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2017 | 582 | 0.470 |
Why?
|
| Liver Cirrhosis | 3 | 2020 | 1960 | 0.430 |
Why?
|
| Phantoms, Imaging | 8 | 2024 | 2512 | 0.420 |
Why?
|
| Aptamers, Nucleotide | 1 | 2014 | 163 | 0.410 |
Why?
|
| Brain Neoplasms | 7 | 2022 | 9118 | 0.390 |
Why?
|
| Fibrosis | 2 | 2020 | 2081 | 0.380 |
Why?
|
| Contrast Media | 10 | 2023 | 5330 | 0.370 |
Why?
|
| Molecular Imaging | 5 | 2020 | 826 | 0.350 |
Why?
|
| Lysine | 1 | 2015 | 1000 | 0.350 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2019 | 3390 | 0.340 |
Why?
|
| Neovascularization, Pathologic | 5 | 2016 | 2631 | 0.340 |
Why?
|
| Magnetic Resonance Spectroscopy | 8 | 2022 | 3782 | 0.330 |
Why?
|
| Plaque, Amyloid | 1 | 2014 | 769 | 0.330 |
Why?
|
| Manganese | 5 | 2016 | 394 | 0.310 |
Why?
|
| Energy Transfer | 1 | 2008 | 109 | 0.300 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2019 | 2486 | 0.300 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2010 | 264 | 0.300 |
Why?
|
| Sirolimus | 1 | 2015 | 1540 | 0.300 |
Why?
|
| Electron Spin Resonance Spectroscopy | 6 | 2000 | 161 | 0.280 |
Why?
|
| Arginine | 3 | 2022 | 932 | 0.280 |
Why?
|
| Spin Labels | 2 | 2008 | 336 | 0.280 |
Why?
|
| Glioma | 3 | 2011 | 3503 | 0.270 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2023 | 9016 | 0.260 |
Why?
|
| Disease Models, Animal | 12 | 2020 | 18349 | 0.250 |
Why?
|
| Magnetics | 2 | 2008 | 597 | 0.250 |
Why?
|
| Mice | 26 | 2023 | 82049 | 0.240 |
Why?
|
| Animals | 34 | 2023 | 169285 | 0.240 |
Why?
|
| Magnetite Nanoparticles | 2 | 2017 | 312 | 0.230 |
Why?
|
| Quinazolines | 5 | 2016 | 1373 | 0.220 |
Why?
|
| Image Enhancement | 4 | 2019 | 2880 | 0.220 |
Why?
|
| Liver | 2 | 2020 | 7578 | 0.210 |
Why?
|
| Blood Vessels | 4 | 2014 | 1110 | 0.210 |
Why?
|
| Rats | 6 | 2020 | 23782 | 0.200 |
Why?
|
| Water | 4 | 2013 | 1421 | 0.200 |
Why?
|
| Ferrosoferric Oxide | 2 | 2017 | 348 | 0.190 |
Why?
|
| Pancreas | 2 | 2020 | 1699 | 0.190 |
Why?
|
| Algorithms | 8 | 2024 | 14164 | 0.190 |
Why?
|
| Ice | 1 | 2022 | 102 | 0.190 |
Why?
|
| Tissue Distribution | 4 | 2017 | 2300 | 0.190 |
Why?
|
| Threonine | 4 | 1998 | 273 | 0.180 |
Why?
|
| p120 GTPase Activating Protein | 1 | 2000 | 35 | 0.180 |
Why?
|
| Elasticity Imaging Techniques | 2 | 2016 | 398 | 0.180 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2000 | 69 | 0.180 |
Why?
|
| Arteriosclerosis | 1 | 2005 | 1055 | 0.180 |
Why?
|
| Rats, Wistar | 3 | 2020 | 1890 | 0.170 |
Why?
|
| Protein Engineering | 1 | 2023 | 553 | 0.160 |
Why?
|
| Programming Languages | 1 | 2019 | 132 | 0.160 |
Why?
|
| Body Temperature | 1 | 2022 | 780 | 0.160 |
Why?
|
| Reproducibility of Results | 8 | 2022 | 20225 | 0.160 |
Why?
|
| Glioblastoma | 4 | 2016 | 3464 | 0.150 |
Why?
|
| Carbon Tetrachloride | 1 | 2017 | 72 | 0.150 |
Why?
|
| Blood-Brain Barrier | 3 | 2013 | 1035 | 0.140 |
Why?
|
| Computer Simulation | 7 | 2023 | 6283 | 0.140 |
Why?
|
| Herpesvirus 1, Human | 1 | 2023 | 743 | 0.140 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 4 | 1998 | 1767 | 0.140 |
Why?
|
| Biosensing Techniques | 1 | 2023 | 662 | 0.140 |
Why?
|
| Nanoparticles | 3 | 2017 | 1986 | 0.140 |
Why?
|
| Half-Life | 1 | 2017 | 651 | 0.130 |
Why?
|
| Amines | 1 | 2018 | 280 | 0.130 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2016 | 112 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2011 | 5704 | 0.120 |
Why?
|
| Chelating Agents | 1 | 2016 | 385 | 0.120 |
Why?
|
| Antibodies, Neoplasm | 1 | 2016 | 283 | 0.120 |
Why?
|
| Blood Volume | 2 | 2013 | 545 | 0.120 |
Why?
|
| Brain | 7 | 2022 | 27362 | 0.120 |
Why?
|
| Ligation | 1 | 2015 | 446 | 0.110 |
Why?
|
| Bile Ducts | 1 | 2015 | 288 | 0.110 |
Why?
|
| Rats, Inbred F344 | 1 | 2015 | 826 | 0.110 |
Why?
|
| Base Pairing | 1 | 2014 | 139 | 0.110 |
Why?
|
| Gadolinium DTPA | 2 | 2017 | 823 | 0.110 |
Why?
|
| Peroxidase | 1 | 2016 | 610 | 0.110 |
Why?
|
| Mice, Nude | 4 | 2018 | 3623 | 0.110 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2017 | 681 | 0.110 |
Why?
|
| Quantum Dots | 1 | 2014 | 168 | 0.110 |
Why?
|
| Liposomes | 1 | 2017 | 792 | 0.110 |
Why?
|
| Alzheimer Disease | 2 | 2014 | 8759 | 0.110 |
Why?
|
| Bariatric Surgery | 1 | 2023 | 1001 | 0.100 |
Why?
|
| Neuropilin-1 | 1 | 2013 | 91 | 0.100 |
Why?
|
| Monte Carlo Method | 1 | 2018 | 1259 | 0.100 |
Why?
|
| Microwaves | 2 | 2011 | 184 | 0.100 |
Why?
|
| Mannitol | 1 | 2012 | 176 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2023 | 1298 | 0.100 |
Why?
|
| Pregnancy Proteins | 1 | 2013 | 222 | 0.100 |
Why?
|
| Cysteine | 1 | 2016 | 897 | 0.100 |
Why?
|
| Escherichia coli | 2 | 2023 | 4213 | 0.100 |
Why?
|
| Sensitivity and Specificity | 5 | 2018 | 14729 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4280 | 0.090 |
Why?
|
| Simplexvirus | 1 | 2015 | 805 | 0.090 |
Why?
|
| Peptides | 3 | 2024 | 4354 | 0.090 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 1230 | 0.090 |
Why?
|
| Immunoblotting | 1 | 2014 | 1648 | 0.090 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2017 | 1124 | 0.090 |
Why?
|
| Islets of Langerhans | 1 | 2017 | 1351 | 0.090 |
Why?
|
| Cell Line, Tumor | 7 | 2020 | 17142 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 2 | 2020 | 5442 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 2202 | 0.090 |
Why?
|
| Doxorubicin | 1 | 2017 | 2234 | 0.090 |
Why?
|
| Breast Neoplasms | 4 | 2023 | 21207 | 0.080 |
Why?
|
| Fibrin | 1 | 2012 | 514 | 0.080 |
Why?
|
| Microscopy, Video | 1 | 2010 | 241 | 0.080 |
Why?
|
| Meningeal Neoplasms | 1 | 2018 | 1253 | 0.080 |
Why?
|
| Linear Models | 1 | 2019 | 5884 | 0.080 |
Why?
|
| Extracellular Space | 1 | 2011 | 563 | 0.080 |
Why?
|
| Diffusion | 1 | 2011 | 815 | 0.080 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2020 | 1756 | 0.080 |
Why?
|
| Angiopoietin-2 | 1 | 2010 | 186 | 0.080 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 13422 | 0.080 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2011 | 508 | 0.080 |
Why?
|
| Humans | 32 | 2024 | 768171 | 0.080 |
Why?
|
| Neoadjuvant Therapy | 1 | 2020 | 2907 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2020 | 3612 | 0.080 |
Why?
|
| Carbon Dioxide | 1 | 2012 | 1148 | 0.070 |
Why?
|
| Cerebellar Neoplasms | 1 | 2013 | 591 | 0.070 |
Why?
|
| Gene Amplification | 1 | 2012 | 1095 | 0.070 |
Why?
|
| Medulloblastoma | 1 | 2013 | 683 | 0.070 |
Why?
|
| Macrophages | 2 | 2016 | 5802 | 0.070 |
Why?
|
| Drug Delivery Systems | 2 | 2017 | 2237 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 548 | 0.070 |
Why?
|
| Capillary Permeability | 1 | 2011 | 772 | 0.070 |
Why?
|
| ROC Curve | 1 | 2015 | 3628 | 0.070 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 2666 | 0.070 |
Why?
|
| Stavudine | 1 | 2007 | 85 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 22380 | 0.070 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2013 | 1429 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2014 | 1931 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2014 | 5028 | 0.070 |
Why?
|
| Vibration | 1 | 2008 | 335 | 0.060 |
Why?
|
| Mitochondria, Muscle | 1 | 2007 | 172 | 0.060 |
Why?
|
| Radio Waves | 2 | 2005 | 250 | 0.060 |
Why?
|
| Apoptosis | 1 | 2021 | 9527 | 0.060 |
Why?
|
| Cerebellum | 1 | 2013 | 1522 | 0.060 |
Why?
|
| Software | 1 | 2019 | 4480 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 9561 | 0.060 |
Why?
|
| Indoles | 2 | 2011 | 1836 | 0.060 |
Why?
|
| Brain Edema | 1 | 2009 | 601 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 2565 | 0.060 |
Why?
|
| Crystallography, X-Ray | 2 | 2000 | 1951 | 0.060 |
Why?
|
| Molecular Structure | 2 | 2016 | 1884 | 0.060 |
Why?
|
| Oligonucleotides | 1 | 2007 | 563 | 0.060 |
Why?
|
| Microscopy | 1 | 2009 | 909 | 0.060 |
Why?
|
| Guanylyl Imidodiphosphate | 3 | 1998 | 37 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3604 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2020 | 9419 | 0.060 |
Why?
|
| Pulsatile Flow | 1 | 2005 | 320 | 0.060 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2007 | 620 | 0.050 |
Why?
|
| Molecular Probes | 2 | 2020 | 309 | 0.050 |
Why?
|
| Glycine | 2 | 2011 | 672 | 0.050 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2009 | 952 | 0.050 |
Why?
|
| Protamines | 1 | 2023 | 112 | 0.050 |
Why?
|
| Binding Sites | 4 | 2000 | 6019 | 0.050 |
Why?
|
| Base Sequence | 1 | 2014 | 12422 | 0.050 |
Why?
|
| Thymidine Kinase | 1 | 2023 | 286 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2010 | 6124 | 0.050 |
Why?
|
| Carbon Isotopes | 1 | 2003 | 458 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2015 | 19025 | 0.050 |
Why?
|
| Receptor, erbB-2 | 1 | 2012 | 2603 | 0.050 |
Why?
|
| Male | 12 | 2023 | 364731 | 0.050 |
Why?
|
| Antineoplastic Agents | 3 | 2016 | 13677 | 0.050 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2007 | 752 | 0.050 |
Why?
|
| Visual Cortex | 1 | 2009 | 1094 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 17623 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 2830 | 0.050 |
Why?
|
| Creatine | 1 | 2023 | 427 | 0.050 |
Why?
|
| Reference Values | 1 | 2008 | 4939 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2007 | 1505 | 0.040 |
Why?
|
| Chemistry, Physical | 1 | 2000 | 153 | 0.040 |
Why?
|
| Chalcones | 1 | 2020 | 32 | 0.040 |
Why?
|
| Chemical Phenomena | 1 | 2000 | 486 | 0.040 |
Why?
|
| Solutions | 1 | 2000 | 409 | 0.040 |
Why?
|
| Fourier Analysis | 1 | 2000 | 439 | 0.040 |
Why?
|
| Propionates | 1 | 2020 | 180 | 0.040 |
Why?
|
| Heterocyclic Compounds | 1 | 2020 | 245 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2000 | 591 | 0.040 |
Why?
|
| Ribonucleotide Reductases | 1 | 1999 | 75 | 0.040 |
Why?
|
| Artifacts | 1 | 2007 | 1926 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2012 | 10478 | 0.040 |
Why?
|
| Guanosine Triphosphate | 2 | 1996 | 315 | 0.040 |
Why?
|
| Amides | 1 | 2021 | 452 | 0.040 |
Why?
|
| Leucovorin | 1 | 2020 | 643 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 2000 | 1435 | 0.040 |
Why?
|
| Diagnostic Imaging | 2 | 2012 | 3533 | 0.040 |
Why?
|
| Heart Failure | 1 | 2022 | 11879 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2013 | 2014 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 3428 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2000 | 1683 | 0.040 |
Why?
|
| Cations, Divalent | 1 | 1997 | 167 | 0.040 |
Why?
|
| Diethylnitrosamine | 1 | 2016 | 45 | 0.040 |
Why?
|
| Amino Acids | 1 | 2023 | 1716 | 0.030 |
Why?
|
| Oleic Acid | 1 | 2017 | 91 | 0.030 |
Why?
|
| Organometallic Compounds | 1 | 2020 | 648 | 0.030 |
Why?
|
| Carbocyanines | 1 | 2017 | 177 | 0.030 |
Why?
|
| Equipment Design | 1 | 2005 | 3522 | 0.030 |
Why?
|
| Female | 10 | 2023 | 397187 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2016 | 6229 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2000 | 1743 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 2004 | 0.030 |
Why?
|
| Pancreatectomy | 1 | 2020 | 825 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2022 | 1440 | 0.030 |
Why?
|
| Glycerol | 2 | 2011 | 274 | 0.030 |
Why?
|
| Temperature | 1 | 2022 | 2234 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2020 | 1652 | 0.030 |
Why?
|
| Heart | 1 | 2008 | 4446 | 0.030 |
Why?
|
| Glucose | 1 | 2007 | 4352 | 0.030 |
Why?
|
| Virus Replication | 1 | 2023 | 2458 | 0.030 |
Why?
|
| Immunohistochemistry | 3 | 2016 | 11095 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2022 | 1812 | 0.030 |
Why?
|
| Transplantation, Heterologous | 2 | 2013 | 2393 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2020 | 10099 | 0.030 |
Why?
|
| Albumins | 1 | 2017 | 577 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2003 | 2149 | 0.030 |
Why?
|
| Adenocarcinoma | 2 | 2012 | 6395 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2014 | 2057 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2007 | 3007 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2016 | 719 | 0.030 |
Why?
|
| Silicon Dioxide | 1 | 2014 | 218 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 7609 | 0.030 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2014 | 254 | 0.030 |
Why?
|
| Particle Size | 1 | 2017 | 1651 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 2395 | 0.020 |
Why?
|
| Trypan Blue | 1 | 2011 | 20 | 0.020 |
Why?
|
| Swine | 1 | 2022 | 5997 | 0.020 |
Why?
|
| Fluorescence | 1 | 2014 | 757 | 0.020 |
Why?
|
| Collagen | 1 | 2020 | 2645 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 4978 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 1623 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4585 | 0.020 |
Why?
|
| Mucin-1 | 1 | 2016 | 537 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2013 | 279 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2022 | 2907 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2012 | 342 | 0.020 |
Why?
|
| Stroke | 1 | 2013 | 9755 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2000 | 5402 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2012 | 630 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 2227 | 0.020 |
Why?
|
| Alkaloids | 1 | 2011 | 192 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2022 | 3334 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2023 | 3941 | 0.020 |
Why?
|
| Proline | 1 | 2011 | 455 | 0.020 |
Why?
|
| Electromagnetic Fields | 1 | 2011 | 289 | 0.020 |
Why?
|
| Optics and Photonics | 1 | 2011 | 307 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 6847 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 1994 | 948 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2013 | 23648 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2013 | 560 | 0.020 |
Why?
|
| Myocardium | 1 | 2022 | 4790 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1996 | 3956 | 0.020 |
Why?
|
| Microcirculation | 1 | 2013 | 1281 | 0.020 |
Why?
|
| Necrosis | 1 | 2012 | 1616 | 0.020 |
Why?
|
| Proteins | 1 | 2023 | 6009 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 6231 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 4913 | 0.020 |
Why?
|
| Photons | 1 | 2011 | 594 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2008 | 11519 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 2065 | 0.020 |
Why?
|
| Cell Death | 1 | 2012 | 1680 | 0.020 |
Why?
|
| Genes, fos | 1 | 2007 | 176 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2007 | 6975 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2023 | 54924 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2012 | 1906 | 0.020 |
Why?
|
| Glucose Clamp Technique | 1 | 2007 | 263 | 0.020 |
Why?
|
| Phosphocreatine | 1 | 2007 | 261 | 0.020 |
Why?
|
| Quinolines | 1 | 2011 | 772 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11878 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2011 | 1461 | 0.020 |
Why?
|
| Phosphorus | 1 | 2007 | 336 | 0.020 |
Why?
|
| Ferric Compounds | 1 | 2007 | 376 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 5756 | 0.010 |
Why?
|
| Carotid Artery, Internal | 1 | 2007 | 440 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2007 | 1989 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12077 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2012 | 2211 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2007 | 1904 | 0.010 |
Why?
|
| GTP Phosphohydrolases | 2 | 1998 | 525 | 0.010 |
Why?
|
| Metal Nanoparticles | 1 | 2007 | 406 | 0.010 |
Why?
|
| Diet | 1 | 2020 | 8089 | 0.010 |
Why?
|
| Nanotechnology | 1 | 2007 | 714 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2007 | 872 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2012 | 5315 | 0.010 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2012 | 2815 | 0.010 |
Why?
|
| Obesity | 1 | 2023 | 13091 | 0.010 |
Why?
|
| Protein Binding | 2 | 2007 | 9343 | 0.010 |
Why?
|
| Cell Survival | 1 | 2010 | 5789 | 0.010 |
Why?
|
| Kinetics | 2 | 1998 | 6330 | 0.010 |
Why?
|
| Carotid Stenosis | 1 | 2007 | 859 | 0.010 |
Why?
|
| Allyl Compounds | 1 | 1999 | 22 | 0.010 |
Why?
|
| Middle Aged | 3 | 2023 | 223487 | 0.010 |
Why?
|
| Benzene Derivatives | 1 | 1999 | 51 | 0.010 |
Why?
|
| Bacteriophages | 1 | 2003 | 382 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 30009 | 0.010 |
Why?
|
| Polystyrenes | 1 | 1999 | 105 | 0.010 |
Why?
|
| Methylglucosides | 1 | 1998 | 35 | 0.010 |
Why?
|
| Free Radicals | 1 | 1999 | 238 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 15949 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39354 | 0.010 |
Why?
|
| Deuterium | 1 | 1998 | 106 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 8052 | 0.010 |
Why?
|
| Transducers | 1 | 1999 | 243 | 0.010 |
Why?
|
| Freezing | 1 | 1998 | 311 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2016 | 65379 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2013 | 14488 | 0.010 |
Why?
|
| Cryoprotective Agents | 1 | 1998 | 128 | 0.010 |
Why?
|
| Body Composition | 1 | 2007 | 2462 | 0.010 |
Why?
|
| Spectrum Analysis | 1 | 1999 | 449 | 0.010 |
Why?
|
| Oxygen Isotopes | 1 | 1996 | 43 | 0.010 |
Why?
|
| Models, Biological | 1 | 2013 | 9497 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1996 | 354 | 0.010 |
Why?
|
| Anisotropy | 1 | 1999 | 1292 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 9262 | 0.010 |
Why?
|
| Time Factors | 2 | 2012 | 40220 | 0.010 |
Why?
|
| Tyrosine | 1 | 1999 | 1427 | 0.010 |
Why?
|
| Guanosine Diphosphate | 1 | 1994 | 79 | 0.010 |
Why?
|
| Asparagine | 1 | 1994 | 120 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2007 | 3986 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 1994 | 577 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 81760 | 0.010 |
Why?
|
| Phosphates | 1 | 1994 | 765 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 171502 | 0.000 |
Why?
|
| Ligands | 1 | 1994 | 3284 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1994 | 6512 | 0.000 |
Why?
|
| Adult | 1 | 2007 | 223646 | 0.000 |
Why?
|